Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer.
The autoimmune disorder of Lambert-Eaton myasthenic syndrome (LEMS) associates with small cell lung carcinoma (SCLC) in 50-60% of cases. It has been postulated that patients who harbour paraneoplastic neurological syndromes such as LEMS have an improved tumour prognosis compared to other patients wi...
Main Authors: | Maddison, P, Lang, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
Paraneoplastic autoimmunity and small‐cell lung cancer: Neurological and serological accompaniments
by: Anastasia Zekeridou, et al.
Published: (2019-04-01) -
Paraneoplastic neurological syndromes of small cell lung cancer
by: Maedeh Barahman, et al.
Published: (2024-07-01) -
THE UTILITY OF SOX ANTIBODIES FOR CANCER PREDICTION IN PATIENTS WITH PARANEOPLASTIC NEUROLOGICAL DISORDERS
by: Maddison, P, et al.
Published: (2012) -
Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long‐term survival in limited stage small‐cell lung cancer
by: Vinicius Ernani, et al.
Published: (2022-04-01) -
Editorial: Autoimmunity and the Brain: Paraneoplastic Neurological Injury and Beyond
by: John E. Greenlee, et al.
Published: (2022-05-01)